Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,197 | 180,878 | 59,150 | 8,641 | 4,573 |
| Marketable Securities | 113,178 | N/A | N/A | N/A | N/A |
| TOTAL | $174,333 | $183,102 | $59,309 | $9,604 | $4,676 |
| Non-Current Assets | |||||
| PPE Net | 186 | 162 | 35 | 37 | 39 |
| Other Non-Current Assets | 844 | 861 | 3,090 | 307 | 0 |
| TOTAL | $1,030 | $1,023 | $3,125 | $344 | $39 |
| Total Assets | $175,363 | $184,125 | $62,434 | $9,948 | $4,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,208 | 2,555 | 3,042 | 1,550 | 618 |
| Accrued Expenses | 1,150 | 1,123 | 1,151 | 232 | 1,156 |
| TOTAL | $2,550 | $3,825 | $4,193 | $1,782 | $1,774 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 395 | 452 | 79,819 | 24,281 | 16,285 |
| TOTAL | $395 | $452 | $79,819 | $24,281 | $16,285 |
| Total Liabilities | $2,945 | $4,277 | $84,012 | $26,063 | $18,059 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 696 | 696 | 696 | N/A | N/A |
| Common Shares | 2 | 2 | N/A | N/A | N/A |
| Retained earnings | -36,392 | -28,169 | -21,985 | -16,201 | -13,407 |
| Other shareholders' equity | -59 | 0 | 0 | 0 | 0 |
| TOTAL | $172,418 | $179,848 | $-21,578 | $-16,115 | $-13,344 |
| Total Liabilities And Equity | $175,363 | $184,125 | $62,434 | $9,948 | $4,715 |